Upregulation of miR-146a contributes to the suppression of inflammatory responses in LPS-induced acute lung injury

Experimental Lung Research

Volumn 39, Issue 7, 2013, Pages 275-282

  Zeng, Zhenguo ^a   Gong, Honghan ^a   Li, Yong ^a   Jie, Kemin ^a   Ding, Chengzhi ^a   Shao, Qiang ^a   Liu, Fen ^a   Zhan, Yian ^a   Nie, Cheng ^a   Zhu, Weifeng ^a   Qian, Kejian ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Alveolar macrophages; MicroRNA 146a

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA 146A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ACUTE LUNG INJURY; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MICRORNAS; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84883011745     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.808285     Document Type: Article

References (39)

1. Rubenfeld, GD: Epidemiology of acute lung injury. Crit Care Med. 2003:S276-S284. (Pubitemid 36458180)
2. Network, T.A.R.D.S.: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-1308.
3. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327-336.
4. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH: Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161:1268-1279. (Pubitemid 32679576)
5. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
6. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E: Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996;24:1285-1292. (Pubitemid 26262400)
7. Kawano T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, Bryan AC: Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol. 1987;62:27-33. (Pubitemid 17060592)
8. Crimi E, Slutsky AS: Inflammation and the acute respiratory distress syndrome. Best Pract Res Clin Anaesthesiol. 2004;18:477-492. (Pubitemid 38949969)
9. Bartel DP, Chen CZ: Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 2004;5:396-400. (Pubitemid 38529411)
10. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179:5082-5089.
11. Iliopoulos D, Hirsch HA, Struhl K: An epigenetic switch involvingNF-kappaB, Lin28, Let-7MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139:693-706.
12. Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M: Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med. 2009;1:288-295.
13. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103:12481-12486. (Pubitemid 44267285)
14. Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA: Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett. 2009;583:3349-3355.
15. Wu YW, Bai M, Zhang JC, Jin Y, Zhang L, Bao B: The effect of nitric oxide inhalation on the expression of COX-2 and tolllike receptor 4 in rat acute lung injury induced by lipopolysaccharide. Zhonghua Jie He He Hu Xi Za Zhi. 2009;32:111-114.
16. Wu CL, Lin LY, Yang JS, Chan MC,Hsueh CM: Attenuation of lipopolysaccharide-induced acute lung injury by treatment with IL-10. Respirology. 2009;14:511-521.
17. EttensohnDB, Jankowski MJ, Redondo AA, Duncan PG: Bronchoalveolar lavage in the normal volunteer subject. 2. Safety and results of repeated BAL, and use in the assessment of intrasubject variability. Chest. 1988;94:281-285.
18. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S: Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science. 2006;311:1141-1146.
19. Garcia-Ramallo E, Marques T, Prats N, Beleta J, Kunkel SL, Godessart N: Resident cell chemokine expression serves as the majormechanism for leukocyte recruitment during local inflammation. J Immunol. 2002;169:6467-6473. (Pubitemid 36903497)
20. Lomas-Neira J, Chung CS, Perl M, Gregory S, Biffl W, Ayala A: Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol. 2006;290:L51-L58.
21. Zhu T,Wang DX, ZhangW, Liao XQ, Guan X, Bo H, Sun JY, Huang NW, He J, Zhang YK, Tong J, Li CY: Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-kappaB. PLoS One. 2013; 8:e56407.
22. Cabrera-Benitez NE, Perez-Roth E, Casula M, Ramos-Nuez A, Rios-Luci C, Rodriguez-Gallego C, Sologuren I, Jakubkiene V, Slutsky AS, Padron JM, Villar J: Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury model. PLoS One. 2012;7:e48468.
23. Huang Y, Crawford M, Higuita-Castro N, Nana-Sinkam P, Ghadiali SN: miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium. FASEB J. 2012;26:3351-3364.
24. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782-787.
25. Wu ZH, Miyamoto S: Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med (Berl). 2007;85:1187-1202. (Pubitemid 47622222)
26. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit CA: A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediatedNFkappaB activation. Mol Cell. 2010;40:63-74.
27. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF: miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA. 2007;104:7080-7085. (Pubitemid 47186012)
28. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC,Wang J, Rajewsky N, Bender TP, Rajewsky K: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007;131:146-159. (Pubitemid 47498525)
29. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA: Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010;11:141-147.
30. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P: MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA. 2009;106:2735-2740.
31. Bazzoni F, Rossato M, FabbriM, Gaudiosi D,Mirolo M,Mori L, Tamassia N,Mantovani A, Cassatella MA, LocatiM: Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. ProcNatl Acad Sci USA. 2009;106:5282-5287.
32. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, Abraham E: miR-147, a microRNA that is induced upon Tolllike receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA. 2009;106: 15819-15824.
33. Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F, Boshoff C: miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional coactivator. Nat Cell Biol. 2010;12:513-519.
34. Moschos SA, Williams AE, Perry MM, BirrellMA, BelvisiMG, Lindsay MA: Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharideinduced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics. 2007;8:240.
35. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A: Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608-611. (Pubitemid 46683148)
36. Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E: Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol. 2009;182:2578-2582.
37. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D: Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001-1009. (Pubitemid 351564001)
38. Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, Yasunaga Y, Asahara H, Ochi M: Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum. 2009;60:1035-1041.
39. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA: Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008;180:5689-5698.